Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

ConditionsNon Muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Neoplasms Non-Muscle Invasive Bladder Urothelial Carcinoma Bladder Cancer Bladder Disease Bladder Neoplasm Bladder Urothelial Carcinoma Bladder Cancer Stage I, With Cancer in Situ Bladder Cancer Recurrent Bladder Urothelial Carcinoma in Situ Bladder Urothelial Dysplasia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorIRCCS San Raffaele

About this trial

A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years or older

Patients with non-muscle invasive bladder cancer

Indication to cancer removal through endoscopic resection surgery

Ability to read and sign the informed consent

Disqualifiers

Age <18 years

Inability to read and sign the informed consent

Trial population

Patients with non muscle-invasive bladder cancer who underwent one of the following endoscopic resection surgeries : TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

20,000 Participants

are grouped into 1 trial group

Group A: Patients with non-muscle invasive bladder cancer

Trial outcomes

Primary outcomes

obtain health benefit for the patients themselves and for future patients suffering from bladder cancer

All patients, before underwent endoscopic resection surgery, receive a diary in which we ask a detailed clinical history of the patient with their symptoms, diagnosis and previous urological e non urological treatments performed before the operation. A detailed intraoperative, postoperative and follow-up clinical history

Time frame

1 Annual follow-up from the date of surgery until the date in which patient decides to stop providing follow-up responses or until the date of death from any cause.

improve the patient's scientific knowledge and develop new procedures for the diagnosis and treatment of the patient

Through the collection of a detailed clinical history of the patient in which themselves report symptoms, diagnosis and previous urological and non-urological treatments and also through the medical record.

Time frame

1 Annual follow-up from the date of surgery untile the date in which patient decides to stop providing follow-up responses or until the date of death from any cause.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS San Raffaele

Lead sponsor

Source ClinicalTrials.gov

Apply now